Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
about
Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing's sarcoma cell line.Resveratrol in management of bone and spinal cancers.
P2860
Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Reverse chemomodulatory effect ...... e-induced anticancer activity.
@en
Reverse chemomodulatory effect ...... e-induced anticancer activity.
@nl
type
label
Reverse chemomodulatory effect ...... e-induced anticancer activity.
@en
Reverse chemomodulatory effect ...... e-induced anticancer activity.
@nl
prefLabel
Reverse chemomodulatory effect ...... e-induced anticancer activity.
@en
Reverse chemomodulatory effect ...... e-induced anticancer activity.
@nl
P2093
P2860
P1476
Reverse chemomodulatory effect ...... e-induced anticancer activity.
@en
P2093
Annelie Blumrich
James F Beck
Jürgen Sonnemann
Lisa Blümel
Melanie Kahl
Priyanka M Siranjeevi
René Winkler
Sabine Becker
Susan Wittig
P2860
P2888
P356
10.1007/S00432-015-1994-2
P577
2015-06-09T00:00:00Z